On October 25th and 26th, 2017, the first combined client conference for Polaris, R-Squared and IMS Health customers was held.
With the addition of Polaris to the IQVIA family, the event was expanded to cover topics beyond transparency reporting, including best practices in HCP management prior to spend reporting, best practices in grants management and what to expect in 2018 in the compliance landscape.
The event was incredibly well received by attendees with a packed agenda of expert speakers, knowledge sharing and ability for attendees to network with peers within the industry.
One of the highlights of the conference was a session by the Chief of the Health Care and Government Fraud Unit at the U.S. Attorney’s Office for the District of New Jersey, who provided the DOJ perspective on “The Importance of Proactive Processes, Controls and Data Analysis.” Within this session, the Chief provided the audience a view on how the DOJ approaches looking at data including that provided by the Open Payments program in investigating the possibility of impropriety in the conduct of business relationships with HCPs.
Another highlight of the event was a panel discussion on the “Evolution of Transparency Initiatives with Life Sciences Companies.” As part of the discussion on the panel, we engaged the conference attendees via audience polling to learn more about client’s experiences. Attendees were able to compare their views with those of their peers in the audience. Below is a summary of the polling results.
2017 CMS Submissions
In 2017, the majority of attendees said they spent most of time on CMS resubmissions for updates for current and previous years. This was followed by the capturing of research payments and managing cross-border payments.
In terms of HCP engagement outside of the CMS dispute process, the majority of respondents indicated they did not engage HCPs or they did so through their field representatives, digital channels (e.g., direct mail) and pre-disclosure notifications.
In analyzing data, we asked our attendees what insights were they most interested in. An overwhelming majority indicated they were interested in identifying HCP outliers, followed by HCP payment limits monitoring, and sales and marketing analysis. These results were not surprising as a focus on activities that do not represent the norm is always a concern as how it may be interpreted by investigators or even the general public.
More than half of all attendees reported that over the next year, their primary focus will be on global transparency and governance. This is consistent with the results of our 2017 industry survey, where nearly 50% of respondents said they’d be increasing their compliance and transparency investment to address global and US state/federal requirements.